Clinical Trial Update: Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating G-CSF in severe alcoholic hepatitis with incomplete steroid response; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Alcoholic Hepatitis | Phase 3 | Status: TERMINATED